MA
HALO icon

Montag & Associates’s Halozyme HALO Stock Holding History

Montag & Associates’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46K Hold
19
– – ﹤0.01% 902
2026
Q1 		$1.21K Buy
19
+1
+6% +$70 ﹤0.01% 886
2025
Q4 		$1.2K Sell
18
-48
-73% -$3.23K ﹤0.01% 913
2025
Q3 		$4.85K Buy
66
+46
+230% +$3.06K ﹤0.01% 828
2025
Q2 		$1.06K Sell
20
-4
-17% -$228 ﹤0.01% 908
2025
Q1 		$1.53K Hold
24
– – ﹤0.01% 917
2024
Q4 		$1.15K Sell
24
-3
-11% -$154 ﹤0.01% 937
2024
Q3 		$1.55K Sell
27
-750
-97% -$43K ﹤0.01% 936
2024
Q2 		$40.7K Hold
777
– – ﹤0.01% 622
2024
Q1 		$31.6K Buy
777
+27
+4% +$1.01K ﹤0.01% 649
2023
Q4 		$27.7K Hold
750
– – ﹤0.01% 663
2023
Q3 		$28.6K Hold
750
– – ﹤0.01% 627
2023
Q2 		$27.1K Buy
+750
New +$25.6K ﹤0.01% 645

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Montag & Associates's HALO Position: Q2 2026 in Review

Montag & Associates held its Halozyme (HALO) position steady in Q2 2026 at 19 shares worth $1.46K. The position accounts for ﹤0.01% of the portfolio, ranked #902.

Montag & Associates first reported a position in HALO in Q2 2023 and has held it in 13 quarters since. The position peaked at $40.7K in Q2 2024. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Montag & Associates held 19 shares of Halozyme worth $1.46K as of Q2 2026.
  • Montag & Associates left its Halozyme share count unchanged in Q2 2026.
  • Halozyme made up ﹤0.01% of Montag & Associates's portfolio in Q2 2026, its #902 holding.
  • Montag & Associates first reported a position in Halozyme in Q2 2023 and has held it in 13 quarters since.
  • Montag & Associates's Halozyme position peaked at $40.7K in Q2 2024.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Montag & Associates's 13F filing for Q2 2026, filed 5 Aug 2026.